Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06503159 · ClinicalTrials.gov registry record · NA
Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06503159 is a NA study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 14 participants.
The verdict
NCT06503159, a NA study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this translational bench-to-bedside study is to examine the neurobiological effects of an evidence-based technology-delivered mindfulness training (MT) program on vaping-related rsFC alterations in hippocampal networks and testing whether changes in rsFC ((Delta)rsFC) in these networks predict reduction in tobacco vaping behaviors in adolescents. The study also aims to test the accessibility and feasibility of using this mindfulness-based stress reduction (MBSR) platform as an implementation for widespread MT in adolescents.
Interventions
- BEHAVIORAL Mindfulness-based Stress Reduction (MBSR) Program
- OTHER functional magnetic resonance imaging (fMRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2025-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06503159
The ClinicalTrials.gov registry entry for NCT06503159 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness-based Stress Reduction (MBSR) Program is the first listed.
NCT06503159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06503159 about?
NCT06503159 is a clinical study titled "Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study". The purpose of this translational bench-to-bedside study is to examine the neurobiological effects of an evidence-based technology-delivered mindfulness training (MT) program on vaping-related rsFC alterations in hippocampal networks and testing whether changes in rsFC ((Delta)rsFC) in these network...
What is the current status of trial NCT06503159?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2025-05-07. Estimated completion is 2025-09-11.
What interventions are being tested in trial NCT06503159?
The interventions under investigation include: Mindfulness-based Stress Reduction (MBSR) Program (BEHAVIORAL), functional magnetic resonance imaging (fMRI) (OTHER).
Who is sponsoring clinical trial NCT06503159?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.